Emzahh Gets FDA Approval for Pregnancy Prevention
Emzahh is an AB-rated generic equivalent of Ortho Micronor.
Diagnosis & Disease Information
Case Study: Ethics and Mental Illness in Pregnancy
A woman is evaluated by psychiatry on postpartum day 2 after staff noticed her talking to the mirror in her room and not showing affection to her newborn child. Case shows ethical decisions made when managing mental illness during pregnancy.
Reforming Institutions, Integrating Health Technology to Address Maternal Mortality Gap
Experts discuss strategies to reduce the maternal mortality gap by implementing implicit bias training and reevaluating clinical guidelines and algorithms.
Symptoms in Late Reproductive Years Similar to Menopause
Authors say findings could help with culturally competent guidance about menopause.
Women With ADHD at Increased Risk for Depression With Hormonal Contraceptive Use
Do women or girls with ADHD using hormonal contraceptives (HCs) have an increased risk for depression compared with HC users who do not have ADHD?
FDA Allows Certified Retail Pharmacies to Dispense Mifepristone
Mifepristone is a progestin antagonist indicated, in a regimen with misoprostol, for the medical termination of intrauterine pregnancy through 70 days gestation.
Maternal Mortality Crisis Among Minority Patients in the US
ACOG experts provide actionable steps to reduce the maternal mortality crisis in the US, particularly among minority populations.
sFlt-1:PlGF Stratifies Risk for Preeclampsia With Severe Features
Ratio had better performance for predicting preeclampsia with severe features than standard clinical measures.
Case Study: 2-Rod Subdermal Contraceptive Implant in a Recent Immigrant
Case involving a 2-rod subdermal contraceptive implant mistaken for a 1-rod device demonstrates the importance of delivering culturally competent care.
USPSTF Recommends Against Postmenopausal Hormone Tx to Prevent Chronic Conditions
The recommendations were give a “D” grade indicating that there is moderate or high certainty that the harms associated with hormone therapy use in these settings outweigh any potential benefits.
- Loading...
Loading...
Next post in Ob/Gyn Information Center
Loading... 
Loading...